Komatsu, H., Enomoto, M., Shiraishi, H., Morita, Y., Hashimoto, D., Nakayama, S., . . . Fujimoto, S. (2020). Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes. Diabetol Int.
Chicago-tyylinen lähdeviittausKomatsu, Hitomi, et al. "Severe Hypoglycemia Caused By a Small Dose of Repaglinide and Concurrent Use of Nilotinib and Febuxostat in a Patient With Type 2 Diabetes." Diabetol Int 2020.
MLA-viiteKomatsu, Hitomi, et al. "Severe Hypoglycemia Caused By a Small Dose of Repaglinide and Concurrent Use of Nilotinib and Febuxostat in a Patient With Type 2 Diabetes." Diabetol Int 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.